In the Middle East and Africa pharmaceutical industry, there were 4 private equity deals announced in Q2 2023, worth a total value of $49.6m, according to GlobalData’s Deals Database. The $45.1m investment by cdg invest and stoa infra and energy in group oncorad was the industry’s largest disclosed deal. A thorough analysis of the disruptive themes, the M&A activity and most notable deals are included in GlobalData’s Pharma Industry Mergers and Acquisitions Deals by Top Themes report. Buy the report here.
In value terms, private equity deal activity in Middle East and Africa decreased by 30% in Q2 2023 compared with the previous quarter’s total of $71.3m. Related deal volume increased by 300% in Q2 2023 versus the previous quarter.
The top-ranked financial advisors supporting these private equity deals in Middle East and Africa in Q2 2023 were Deloitte Touche Tohmatsu; Hc Securities & Investment S.A.E.; PwC India with 1, 1, 1 deals respectively.
The top-ranked legal advisors supporting these private equity deals in Middle East and Africa Q2 2023 were Asafo & Co.; Freshfields Bruckhaus Deringer; Hilmi Law Firm with 1, 1, 1 deals respectively.
For further understanding of GlobalData's Pharma Industry Mergers and Acquisitions Deals by Top Themes, buy the report here.